Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 12 — Responsible Consumption and Production
SDG 16 — Peace, Justice and Strong Institutions
This track focuses on the latest methodologies and technologies in drug discovery, emphasizing innovative approaches to identify and develop new therapeutic agents. Participants will explore case studies and research findings that highlight successful drug development pipelines.
This session will delve into the integration of pharmaceutical sciences into clinical practice, showcasing research that enhances patient care. Discussions will include the role of pharmacists in optimizing therapeutic outcomes through evidence-based practices.
Focusing on the design and synthesis of new chemical entities, this track will cover cutting-edge research in medicinal chemistry. Participants will discuss novel compounds and their potential therapeutic applications in various disease states.
This session will highlight the role of technology in pharmaceutical innovation, including advancements in drug formulation and delivery systems. Attendees will examine how these innovations can improve patient adherence and therapeutic efficacy.
This track will address the critical aspects of drug safety, including monitoring and assessing adverse drug reactions. Discussions will focus on regulatory frameworks and best practices in pharmacovigilance to ensure patient safety.
This session will explore the evolving role of clinical pharmacy in healthcare settings, emphasizing collaborative practices that enhance patient outcomes. Research presentations will highlight successful interventions and their impact on medication management.
Focusing on the pharmacological aspects of drug action, this track will examine the mechanisms of action of various therapeutic agents. Participants will discuss the implications of pharmacology research on clinical practice and drug development.
This session will address the challenges faced in drug formulation and the innovative strategies being employed to overcome them. Topics will include novel excipients, delivery systems, and the impact of formulation on drug bioavailability.
This track will explore the principles of pharmaceutical engineering in the context of drug manufacturing and process optimization. Discussions will focus on the application of engineering solutions to enhance production efficiency and product quality.
This session will examine the strategies for optimizing therapy through personalized medicine, including pharmacogenomics and tailored treatment plans. Participants will discuss the implications of individualized therapy on patient outcomes.
This track will provide insights into the regulatory landscape governing pharmacy research and drug development. Discussions will focus on the challenges and opportunities in navigating regulatory requirements to bring new therapies to market.
SNRI maintains uninterrupted academic processes in the current global situation. Participants can engage and publish through online and blended conference formats.
PLEASE READ: CLOSING ENABLED IN 20S